Contact Us | Useful Links | FAQs | Feedback | Sitemap |
Holdipharma Delegation gave a visit to the newdigging site of the Suez Canal :: Holdipharma welcomes the establishment of a production facility dedicated for production of raw materials :: Egyptian Exchange "Rings the Bell For Gender Equality " :: UNGC principles with holdipharma :: New chairman of Drug Holding Co. :: The Minister of the Business Sector is following up implementation plan :: Minister of Business Sector approved the estimated "DHC budget " 2017/2018 :: President Al Sisi directs the follow-up plans to develop public sector companies :: Minister of Business Sector receives Indian Ambassador :: Drug Holding Company: “Development Committee "ends the study of the Co. structure :: Ministry Of Public Business Sector: completion of the General Assemblies of DHCs :: Minister of Business Sector assigns 3 new members of Board of Directors of the DHC :: Chairman of Drug Holding Company: 11% is our share in the Egyptian drug market :: Captain Mohammed Wanees, one of the heroes of the glorious October War :: Minister of Business Sector: Restructuring the investment portfolio of the companies :: Appointment of a new President of the Drug Holding Company :: Hisham Anwar Tawfiq, Minister of Public Business sector, replacing Khaled Badawi . :: An integrated strategy for the advancement of the Drug Holding Company :: Dr.Ahmed Hegazy Chairman of Holdipharma Company confirm that Holdipharma reaffirms its support for the ten principles of the United Nations Global Compact ::
Company Details
Company Name   Website

Kahira Co. for Pharmaceutical and Chemical Industries was established in 1962 after the integration of three small facilities working in the production of pharmaceutical products (Alpha – Douche – C-pharm) then Beida was joined to this entity later on, they all constituted a concise and limited entity upon that time.

Since 1962, the government decided to expand this entity to be a well-established large scale manufacturing facility and to conclude other production lines for almost all the pharmaceutical dosage forms, to fulfill the extra production demands needed for local market and for most of the Arab countries.

Kahira pharmaceutical company was distinguished as the first one between drug companies in the production of soft gelatin capsules, and the production of Syrups, Lotions, sterile and non-sterile drops, dry powders and granules, ointments and pastes.

The company has a unique sterile dedicated area for the production of cephalosporins that was established by the aid of American expertise and in accordance to the latest international guidelines.

Board Members

Dr/ Mohamed Adel El Tahlawy                     Chairman of the Board Managing Director of the Board

Mr/ Yaser Farook El Masry                          Non Executive Member

Mr/ Galal Imam Abdel Ati                            Non Executive Member

Mrs/ Hayam Mohamed Sakr                        Non Executive Member

Mr/ Ali Ateya El Sayed Shaheen                     Elected  Member 

Mr/ Ahmed Fadel Ibrahim                              Elected  Member

Mr/ Mamdouh Mohamed Mostafa                    Elected  Member

Mr/ Mahmoud Soliman Khalid                         Elected  Member

Audit Committee:

Dr/ Ikhlas Yousef Salem                                Chairman

Mr/ Galal Imam Abdel Ati                            Member

Mr/ Yaser Farook El Masry                          Member

Company Main Indicators (in thousands of Egyptian Pounds)

Indicator 2015-2016 2016-2017 2017-2018
Net Operating Revenue



Interest Expenses 0 0 0
Net Income 51348 97920 450108
Net Equity 409408 521182 373580
Working Capital 336492 432297 238431
Total Investment 414573 830209 844585
Salaries 151108 163304 437174
Number of workers 2617 2627 2502

Image Gallery
Related Links
Joint Venture
  Copyright © 2009 HOLDIPHARMA. All rights reserved.         Terms of Use | Privacy Statement | Disclaimer |